ATC Group: S01GX10 Epinastine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01GX10 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics
4 S01GX Other antiallergics
5 S01GX10 Epinastine

Active ingredients in S01GX10

Active Ingredient

Epinastine is a topically active, direct H1receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2-receptor. Epinastine also possesses affinity for the α1, α2, and 5-HT2–receptors.

Related product monographs

Document Type Information Source  
 ELESTAT Ophthalmic solution MPI, US: SPL/PLR FDA, National Drug Code (US)
 RELESTAT Eye drops, solution MPI, EU: SmPC Health Products Regulatory Authority (IE)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Ecuador (EC)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Go to ATC index
⇈